title: TNF-α antagonist infliximab in the treatment of depression in older adults: results of a prematurely ended, randomized, placebo-controlled trial.
authors.forename: D Willemijn
authors.initials: DW
authors.lastname: Maas
authors.forename: Rudi G J
authors.initials: RG
authors.lastname: Westendorp
authors.forename: Jorien M
authors.initials: JM
authors.lastname: Willems
authors.forename: Anton J M
authors.initials: AJ
authors.lastname: de Craen
authors.forename: Rose C
authors.initials: RC
authors.lastname: van der Mast
mesh_terms: D000367:Age Factors; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000276:immunology / Q000523:psychology; D057239:Early Termination of Clinical Trials / Q000639:trends; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D010865:Pilot Projects; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab